|
Volumn 10, Issue 5, 2014, Pages C79-C81
|
Treatment of mid-late stage NSCLC using sodium cantharidinate/vitamin B6/GP regimen in clinic
|
Author keywords
GP regimen; Non small cell lung carcinoma; Sodium cantharidinate vitamin B6 injection
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
GEMCITABINE;
PYRIDOXINE;
SODIUM CANTHARIDINATE;
UNCLASSIFIED DRUG;
CANTHARIDIN;
DISODIUM CANTHARIDIN;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CARDIOTOXICITY;
CONTINUOUS INFUSION;
CONTROLLED STUDY;
DISEASE SEVERITY;
DIURESIS;
DRUG EFFICACY;
HUMAN;
KIDNEY DYSFUNCTION;
LEUKOPENIA;
LIVER DYSFUNCTION;
MAJOR CLINICAL STUDY;
NAUSEA AND VOMITING;
NON SMALL CELL LUNG CANCER;
OUTCOME ASSESSMENT;
PHLEBITIS;
PRACTICE GUIDELINE;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ADVERSE DRUG REACTION;
ANALOGS AND DERIVATIVES;
CANCER STAGING;
CARCINOMA, NON-SMALL-CELL LUNG;
CHINA;
PATHOLOGY;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CANTHARIDIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CHINA;
DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;
HUMANS;
NEOPLASM STAGING;
QUALITY OF LIFE;
TREATMENT OUTCOME;
VITAMIN B 6;
|
EID: 84907059338
PISSN: 09731482
EISSN: 19984138
Source Type: Journal
DOI: 10.4103/0973-1482.139771 Document Type: Article |
Times cited : (12)
|
References (9)
|